- Tech Times
- Posts
- The Drug That Makes You Younger, Europe's First Private Rocket, and a Zero-Day You Need to Patch Today
The Drug That Makes You Younger, Europe's First Private Rocket, and a Zero-Day You Need to Patch Today
Ayden Noh
September 08, 2026
Hey friend — happy Tuesday! Today's edition is one of those issues where we had to wrestle over which story deserved the top spot, because the heart of today's news sits right at that fascinating crossroads of AI, human health, and geopolitical drama. Grab your coffee and let's dig in.
⭐ Top Story
The AI Drug That's Making People Biologically Younger — and Science Just Confirmed It
Imagine a drug designed from scratch by an AI — not borrowed from diabetes or cancer medicine, but built specifically to target aging. That's rentosertib, developed by Insilico Medicine, and a landmark study published in Nature Biotechnology just found something the longevity world has been chasing for years: six independently built aging clocks — each built by a different research group, using different data and methods — all pointed in the same direction after patients took it, showing measurable reductions in biological age. The catch? The trial was in patients with lung disease, so we still need a healthy-volunteer study to confirm the AI-designed drug is tackling aging itself — not just treating sick lungs — but Nobel laureate Michael Levitt is already calling the cross-model consensus "convincing."
🚀 Quick Hits
History Is Launching on October 19 — Literally Japan's JAXA will send its MMX spacecraft toward Phobos next month, and tucked inside that mission is humanity's first-ever confirmed path to physical Martian material — after Congress cancelled NASA's $11B Mars Sample Return plan, Japan quietly stepped up.
Europe Finally Has Its Own Rocket Story The Spectrum rocket just achieved orbit, making it the first privately funded launch to reach space from continental Europe — a milestone that changes the conversation about who controls access to the stars.
Patch Your Chrome. Now. Seriously. Google quietly pushed a fix for Chrome's sixth zero-day exploit of 2026, this one hiding in the V8 JavaScript engine and already being used in the wild before the patch dropped — if you haven't updated today, put this newsletter down and do it first.
North Korea's Latest Hack Is Genuinely Clever (and Alarming) North Korean operatives reportedly slipped malicious code into HAProxy — the load balancer quietly running on thousands of South Korean servers — essentially turning standard SSL traffic routing into a wiretap. The supply-chain angle here is what makes it particularly unsettling.
Huawei's American Reckoning Has Officially Begun The US government's RICO trial against Huawei opened this week, treating the telecom giant as a criminal enterprise rather than just a trade dispute — a legal escalation that could reshape how Western governments handle tech companies with ties to foreign governments for years to come.
🤖 AI
The AlphaGo Co-Creator Just Walked Away From DeepMind Thore Graepel, one of the minds behind AlphaGo, has left DeepMind — and his parting take is striking: he's betting that structured search will outlast pure LLM scaling as the path to smarter AI. When one of the people who shaped the modern AI era changes direction, it's worth paying attention.
Jane Street Just Put $19 Billion Behind AI Compute The secretive trading firm helped close a $3B funding round for Crusoe, an AI compute company — the kind of number that signals Wall Street isn't hedging on AI infrastructure, they're all in.
🎧 Reviews
Bose QuietComfort at $229 — Should You Grab This Labor Day Deal? The 2nd-gen Bose QuietComfort is sitting at $229 for Labor Day, and our reviewers have some honest thoughts on what changed (and what didn't) since the first generation. If you've been on the fence, this is the breakdown you need before the deal disappears.